Plasma multi-omics reveals molecular remodeling and prognostic biomarkers in advanced breast cancer treated with trastuzumab deruxtecan
Paired plasma multi-omics revealed T-DXd-associated proteomic and metabolic remodeling and the molecular patterns and PFS-associated biomarkers are hypothesis-generating and require validation in larger independent cohorts.
D. Sang, Wen-Yu Yang, Jin-Song Liu et al.
· Frontiers in Oncology · 0 citations